Lite Strategy, Inc.

LITS Stock Healthcare Biotechnology
$1.15
-0.05 (-3.77%)
Price as of Oct 16, 2026 market close

Performance

1 Month
+10.6%
3 Months
+11.7%
YTD
-12.9%
1 Year
-46.0%
3 Year annualized
-40.0%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
80.4%
Largest decline max drawdown, since Oct 2021
-98.6%
Risk-adjusted return Sharpe ratio, 1-year
-0.37

Own LITS?

See how LITS contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.